Site de l'université de Franche-Comté
Neurosciences

Publications 2014

  • Andrieu, P., Bonnans, V., Meneses, J., Millot, J.-L., Moulin, T., and Gharbi, T. (2014). A modular, computer-controlled system for olfactory stimulation in the MRI environment. Behav Res 46, 178–184.
  • Bennabi, D., Pedron, S., Haffen, E., Monnin, J., Peterschmitt, Y., and Van Waes, V. (2014). Transcranial direct current stimulation for memory enhancement: from clinical research to animal models. Front Syst Neurosci 8, 159.
  • Beverley, J.A., Piekarski, C., Van Waes, V., and Steiner, H. (2014). Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates. Basal Ganglia 4, 109–116.
  • Briki, M., Haffen, E., Monnin, J., Tio, G., Nicolier, M., Sechter, D., and Vandel, P. (2014). Sexual dysfunction and depression: Validity of a French version of the ASEX scale. L’Encephale.
  • Chollet, F., Cramer, S.C., Stinear, C., Kappelle, L.J., Baron, J.C., Weiller, C., Azouvi, P., Hommel, M., Sabatini, U., and Moulin, T. (2014). Pharmacological therapies in post stroke recovery: recommendations for future clinical trials. Journal of Neurology.
  • Enderlé, A., Evain, S., Langlois, C., Pasquier, F., Vercelletto, M., and Magnin, E. (2014). Stratification des aphasies progressives primaires selon le profil des biomarqueurs du liquide céphalospinal. Revue Neurologique 170, A4–A5.
  • Fanara, B., Christophe, J.-L., Boillot, A., Tatu, L., Jochum, D., Henri, Y., Berthier, F., and Samain, E. (2014). Ultrasound guidance of needle tip position for femoral nerve blockade: an observational study. Eur J Anaesthesiol 31, 23–29.
  • Gabelle, A.A., Dumurgier, J., Bombois, S., Wallon, D., Blanc, F., Magnin, E., Vercruysse, O., Delaby, C., Hirtz, C., Bousiges, O., et al. (2014). CSF AD BIOMARKERS IN MEMORY CLINIC PATIENTS: THE EP. LM FR STUDY. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 10, P347.
  • Georgin-Lavialle, S., Moura, D.S., Bruneau, J., Chauvet-Gélinier, J.-C., Damaj, G., Soucie, E., Barete, S., Gacon, A.-L., Grandpeix-Guyodo, C., Suarez, F., et al. (2014). Leukocyte telomere length in mastocytosis: correlations with depression and perceived stress. Brain Behav. Immun. 35, 51–57.
  • Greally, M.T., Kalis, N.N., Agab, W., Ardati, K., Giurgea, S., Kornak, U., and Van Maldergem, L. (2014). Autosomal recessive cutis laxa type 2A (ARCL2A) mimicking Ehlers-Danlos syndrome by its dermatological manifestations: Report of three affected patients. American Journal of Medical Genetics Part A.
  • Henriques, J., Gabriel, D., Grigoryeva, L., Haffen, E., Moulin, T., Aubry, R., Pazart, L., and Ortega, J.-P. (2014). Protocol Design Challenges in the Detection of Awareness in Aware Subjects Using EEG Signals. Clin EEG Neurosci.
  • Kastler, A., Cadel, G., Comte, A., Gory, G., Piccand, V., Tavernier, L., and Kastler, B. (2014). Alcohol percutaneous neurolysis of the sphenopalatine ganglion in the management of refractory cranio-facial pain. Neuroradiology 56, 589–596.
  • Lehmann, S., Dumurgier, J., Schraen, S., Wallon, D., Blanc, F., Magnin, E., Bombois, S., Bousiges, O., Campion, D., Cretin, B., et al. (2014a). A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles. Alzheimer’s Research & Therapy 6, 38.
  • Lehmann, S., Dumurgier, J., Schraen, S., Wallon, D., Blanc, F., Magnin, E., Bombois, S., Bousiges, O., Campion, D., Cretin, B., et al. (2014b). Alzheimer’s Research & Therapy.
  • Magnin, E., Ayrignac, X., Berger, E., Mine, M., Tournier-Lasserve, E., and Labauge, P. (2014a). Late Diagnosis of COL4A1 Mutation and Problematic Vascular Risk Factor Management. European Neurology 72, 150.
  • Magnin, E., Blagosklonov, O., Sylvestre, G., Minot, D., Thevenon, J., Faivre, L., Boulahdour, H., Thauvin-Robinet, C., and Rumbach, L. (2014b). Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation. Brain and Development 36, 711–715.
  • Magnin, E., Thomas-Antérion, C., Sylvestre, G., Haffen, S., Magnin-Feysot, V., and Rumbach, L. (2014c). Conversion, dissociative amnesia, and Ganser syndrome in a case of “chameleon” syndrome: Anatomo-functional findings. Neurocase 20, 27–36.
  • Magnin, E., Paquet, C., Formaglio, M., Croisile, B., Chamard, L., Miguet-Alfonsi, C., Tio, G., Dumurgier, J., Roullet-Solignac, I., Sauvée, M., et al. (2014d). Increased cerebrospinal fluid tau levels in logopenic variant of Alzheimer’s disease. J. Alzheimers Dis. 39, 611–616.
  • Mondino, M., Bennabi, D., Poulet, E., Galvao, F., Brunelin, J., and Haffen, E. (2014). Can transcranial direct current stimulation (tDCS) alleviate symptoms and improve cognition in psychiatric disorders? World J. Biol. Psychiatry.
  • Mouton-Liger, F., Wallon, D., Troussière, A.-C., Yatimi, R., Dumurgier, J., Magnin, E., de la Sayette, V., Duron, E., Philippi, N., Beaufils, E., et al. (2014). Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study. Journal of Neurology 261, 144–151.
  • Paillard, A.C., Lamôré, M., Etard, O., Millot, J.-L., Jacquot, L., Denise, P., and Quarck, G. (2014). Is there a relationship between odors and motion sickness? Neurosci. Lett.
  • Pazart, L., Comte, A., Magnin, E., Millot, J.-L., and Moulin, T. (2014a). An fMRI study on the influence of sommeliers’ expertise on the integration of flavor. Front Behav Neurosci 8, 358.
  • Pazart, L., Comte, A., and Magnin, É. (2014b). Importance en neuro-imagerie de l’expertise sur l’intégration de la flaveur d’un vin. Revue Des Oenologues et Des Techniques Vitivinicoles et Oenologicques: Magazine Trimestriel D’information Professionnelle 41, 41–43.
  • Pedron, S., Monnin, J., Haffen, E., Sechter, D., and Van Waes, V. (2014). Repeated transcranial direct current stimulation prevents abnormal behaviors associated with abstinence from chronic nicotine consumption. Neuropsychopharmacology 39, 981–988.
  • Petit, E., Mougin, F., Bourdin, H., Tio, G., and Haffen, E. (2014). A 20-min nap in athletes changes subsequent sleep architecture but does not alter physical performances after normal sleep or 5-h phase-advance conditions. European Journal of Applied Physiology 114, 305–315.
  • Schaefer, E., Collet, C., Genevieve, D., Vincent, M., Sanchez, E., Bolender, C., Eliot, M.-M., Passos-Bueno, M.-R., Wieczorek, D., Van Maldergem, L., et al. (2014). Autosomal recessive POLR1D mutation with decreasing of TCOF1 mRNA is responsible for Treacher-Collins syndrome. Trends Genet.
  • Silvestre, M., Ferreira, S., Berger, E., Magnin, E., and Chamard, L. (2014). Paraplégie spastique familiale de type 4: quels troubles cognitifs? Revue Neurologique 170, A154–A155.
  • Siri, A., Tournier-Lasserve, E., Mine, M., Magnin, E., Berger, E., Arquizan, C., Ayrignac, X., Carra-Dalliere, C., Castelnovo, G., De Champfleur, N., et al. (2014). COL4A1 Mutations: Clinical and Radiological Phenotypes in a French Adult Cohort (S15. 006). Neurology 82, S15–006.
  • Sousa, S.B., Jenkins, D., Chanudet, E., Tasseva, G., Ishida, M., Anderson, G., Docker, J., Ryten, M., Sa, J., Saraiva, J.M., et al. (2014). Gain-of-function mutations in the phosphatidylserine synthase 1 (PTDSS1) gene cause Lenz-Majewski syndrome. Nat Genet 46, 70–76.
  • Steiner, H., Warren, B.L., Van Waes, V., and Bolaños-Guzmán, C.A. (2014). Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior. Prog. Brain Res. 211, 13–30.
  • Tatton-Brown, K., Seal, S., Ruark, E., Harmer, J., Ramsay, E., del Vecchio Duarte, S., Zachariou, A., Hanks, S., O’Brien, E., Aksglaede, L., et al. (2014). Mutations in the DNA methyltransferase, DNMT3A, cause a novel overgrowth syndrome. Nature Genetics.
  • Turjman, F., Levrier, O., Combaz, X., Bonafé, A., Biondi, A., Desal, H., Bracard, S., Mounayer, C., Riva, R., Chapuis, F., et al. (2014). EVIDENCE Trial: design of a phase 2, randomized, controlled, multicenter study comparing flow diversion and traditional endovascular strategy in unruptured saccular wide-necked intracranial aneurysms. Neuroradiology 57, 49–54.

Van Waes, V., Vandrevala, M., Beverley, J., and Steiner, H. (2014). Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a. Addiction Biology.